ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc.


Company website:http://www.acadia-pharm.com

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer’s disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

More info:Click here


ACAD - ACADIA Pharmaceuticals Inc


Country: United States
Currency: USD
Margin: 10%
Is shortable: Yes


Trading hours:
SundayMondayTuesdayWednesdayThursdayFridaySaturday
Market is closed16:30 - 22:5916:30 - 22:5916:30 - 22:5916:30 - 22:5916:30 - 22:59Market is closed

Interest (annually):
Long positionShort position
–4.25% -1.75%

Interest Accrual

Temporary margin requirements due to upcoming corporate events:

Margin Calendar